Cargando…

Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults

Intravenous (IV) edaravone is approved as an amyotrophic lateral sclerosis (ALS) treatment. Because IV administration places a burden on patients, development of orally administered ALS treatments is needed. Therefore, 2 phase 1 studies of oral formulations of edaravone in healthy subjects examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Hidetoshi, Nishimura, Yukiko, Shiide, Yoichi, Matsuda, Hideaki, Akimoto, Makoto, Matsuda, Munetomo, Nakamaru, Yoshinobu, Kato, Yuichiro, Kondo, Kazuoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518673/ https://www.ncbi.nlm.nih.gov/pubmed/33704925 http://dx.doi.org/10.1002/cpdd.925

Ejemplares similares

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
por: Shimizu, Hidetoshi, et al.
Publicado: (2021)

Edaravone Administered Orally and Via Nasogastric Tube in Healthy Adults: A Comparative Bioavailability Phase 1 Study
por: Shimizu, Hidetoshi, et al.
Publicado: (2022)

A Randomized, Single‐Blind, Placebo‐Controlled, 3‐Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects
por: Shimizu, Hidetoshi, et al.
Publicado: (2020)

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
por: Abe, Koji, et al.
Publicado: (2014)

Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
por: Cha, Sun Joo, et al.
Publicado: (2022)

4-Cl-edaravone and (E)-2-chloro-3-[(E)-phenyldiazenyl]-2-butenoic acid are the specific reaction products of edaravone with hypochlorite
por: Amekura, Sakiko, et al.
Publicado: (2020)

Ectopic neurogenesis induced by prenatal antiepileptic drug exposure augments seizure susceptibility in adult mice
por: Sakai, Atsuhiko, et al.
Publicado: (2018)

Karyotype Reorganization in the Hokou Gecko (Gekko hokouensis, Gekkonidae): The Process of Microchromosome Disappearance in Gekkota
por: Srikulnath, Kornsorn, et al.
Publicado: (2015)

Edaravone: a baby in the bathwater?
por: Ludolph, Albert
Publicado: (2017)

Plasma marker of tissue oxidative damage and edaravone as a scavenger drug against peroxyl radicals and peroxynitrite
por: Yamamoto, Yorihiro
Publicado: (2017)

Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone)
por: Masuda, Tomomi, et al.
Publicado: (2017)

Role of edaravone in managemant of septic peritonitis
por: Elbaradey, Ghada Fouad, et al.
Publicado: (2016)

Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug
por: Ortiz, Juan Fernando, et al.
Publicado: (2020)

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)

Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers: Safety and Pharmacokinetics of Single or Multiple Intravenous Infusions
por: Li, Hao, et al.
Publicado: (2012)

Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704
por: Kang, Dong Wook, et al.
Publicado: (2021)

Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study
por: Inagaki, Nobuya, et al.
Publicado: (2015)

Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis
por: Li, Liang-Da, et al.
Publicado: (2023)

Therapeutic Time Window for Edaravone Treatment of Traumatic Brain Injury in Mice
por: Miyamoto, Kazuyuki, et al.
Publicado: (2013)

SUN-199 The Kappa Opioid Receptor (KOR)-Expressing Neurons Localize in the Ventromedial Hypothalamic Nucleus and Project to KNDy Neurons, the GnRH Pulse Generator, in Rats
por: Munetomo, Arisa, et al.
Publicado: (2019)

Effects of Edaravone on Muscle Atrophy and Locomotor Function in Patients with Ischemic Stroke: A Randomized Controlled Pilot Study
por: Naritomi, Hiroaki, et al.
Publicado: (2012)

Edaravone acts as a potential therapeutic drug against pentylenetetrazole‐induced epilepsy in male albino rats by downregulating cyclooxygenase‐II
por: Liu, Liang‐min, et al.
Publicado: (2018)

The Improved Brain-Targeted Drug Delivery of Edaravone Temperature-Sensitive Gels by Ultrasound for γ-ray Radiation-Induced Brain Injury
por: Li, Qian, et al.
Publicado: (2022)

HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1
por: Fujino, Shiki, et al.
Publicado: (2021)

Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy
por: Arumugam, Somasundaram, et al.
Publicado: (2012)

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study
por: Nangaku, Masaomi, et al.
Publicado: (2021)

Analysis of Suspension of Clinical Trials for Drug Registration in China
por: Su, Xian, et al.
Publicado: (2021)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
por: Inagaki, Nobuya, et al.
Publicado: (2014)

Drug Metabolism and Pharmacokinetics
Publicado: (2008)

A radical scavenger edaravone and oligodendrocyte protection/regeneration
por: Takase, Hajime, et al.
Publicado: (2018)

Is Edaravone the Future of Free Radical Scavenging in Inflammatory States?
por: Nair, Abhijit S.
Publicado: (2017)

Effect of edaravone in diabetes mellitus-induced nephropathy in rats
por: Varatharajan, Rajavel, et al.
Publicado: (2016)

Gentamicin Pharmacokinetics and Optimal Dosage in Infant Patients: A Case Report and Literature Review
por: Kato, Hideo, et al.
Publicado: (2022)

Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
por: Hernández Lozano, Irene, et al.
Publicado: (2019)

Testing a Benchtop Wet-Milling Method for Preparing Nanoparticles and Suspensions as Hospital Formulations
por: Kawano, Yayoi, et al.
Publicado: (2021)

A study on the chemical stability of cholesterol-lowering drugs in concomitant simple suspensions with magnesium oxide
por: Kato, Ginjiro, et al.
Publicado: (2023)

Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis
por: Gupta, Sandeep K., et al.
Publicado: (2022)

Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings
por: WATANABE, SHOBU, et al.
Publicado: (2013)

Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations
por: Ronquest, Naoko A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_64nf0718f227agvmcj1uorqgnn